The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Sunahara, R. K., Guan, H.-C., O'Dowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H. M., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,165
The physiology of brain histamine
Brown, R. E., Stevens, D. R., & Haas, H. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00039-3 · Cited by 988
Principles of Multivariate Analysis
Ling, R. F. (1990) · Technometrics · doi:10.1080/00401706.1990.10484645 · Cited by 812
Distinct functions of the two isoforms of dopamine D2 receptors
Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717
Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. L. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 688
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Meneses, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00067-6 · Cited by 475
Principles of Multivariate Analysis: A User’s Perspective
Krzanowski, W. J. (2000) · doi:10.1093/oso/9780198507086.001.0001 · Cited by 467
The dopamine D4 receptor: one decade of research
Oak, J. N., Oldenhof, J., & Van Tol, H. H. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00562-8 · Cited by 419
Aizman, O., Brismar, H., Uhlén, P., Zettergren, E., Levey, A. I., Forssberg, H., Greengard, P., & Aperia, A. (2000) · Nature Neuroscience · doi:10.1038/72929 · Cited by 415
Jellinger, K. A. (1999) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6360-3_1 · Cited by 347
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors
Mierau, J., Schneider, F. J., Ensinger, H. A., Chio, C. L., Lajiness, M. E., & Huff, R. M. (1995) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(95)90013-6 · Cited by 257
Millan, M. J., Lejeune, F., & Gobert, A. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400202 · Cited by 231
Self-citationNEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALS
Sibley, D. R. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.313 · Cited by 222
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
Friedman, J. H., & Factor, S. A. (2000) · Movement Disorders · doi:10.1002/1531-8257(200003)15:2<201::aid-mds1001>3.0.co;2-d · Cited by 214
Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs
Joyce, J. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00139-5 · Cited by 214
Dopamine D5 receptor immunolocalization in rat and monkey brain
Ciliax, B. J., Nash, N., Heilman, C., Sunahara, R., Hartney, A., Tiberi, M., Rye, D. B., Caron, M. G., Niznik, H. B., & Levey, A. I. (2000) · Synapse · doi:10.1002/1098-2396(200008)37:2<125::aid-syn7>3.0.co;2-7 · Cited by 210
Hieble, J. P., Bondinell, W., & Ruffolo, R. R. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a001 · Cited by 209
Wilms, H., Sievers, J., & Deuschl, G. (1999) · Movement Disorders · doi:10.1002/1531-8257(199907)14:4<557::aid-mds1004>3.0.co;2-g · Cited by 198
Newman-Tancredi, A., Cussac, D., Quentric, Y., Touzard, M., Verrièle, L., Carpentier, N., & Millan, M. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039883 · Cited by 194
Self-citationNewman-Tancredi, A., Cussac, D., Audinot, V., Nicolas, J.-P., De Ceuninck, F., Boutin, J.-A., & Millan, M. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039875 · Cited by 179
Self-citationPerachon, S., Schwartz, J.-C., & Sokoloff, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00896-6 · Cited by 169
The economic impact of stroke.
Dobkin, B. H. (1995) · PubMed · Cited by 153
The rationale for the use of dopamine agonists in Parkinson's disease
Jenner, P. G. (1995) · Neurology · doi:10.1212/wnl.45.3_suppl_3.s6 · Cited by 149
An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease
Anichtchik, O. V., Rinne, J. O., Kalimo, H., & Panula, P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7362 · Cited by 146
Millan, M. J., Newman‐Tancredi, A., Quentric, Y., & Cussac, D. (2001) · Psychopharmacology · doi:10.1007/s002130100742 · Cited by 131
Self-citationMillan, M. J., Dekeyne, A., Rivet, J., Dubuffet, T., Lavielle, G., & Brocco, M. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39333-4 · Cited by 128
Self-citationNeuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity
Zou, L., Jankovic, J. J., Rowe, D. B., Xie, W., Appel, S. H., & Le, W. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00062-4 · Cited by 109
Interactions between histaminergic and cholinergic systems in learning and memory
Bacciottini, L., Passani, M. B., Mannaioni, P. F., & Blandina, P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00230-3 · Cited by 98
Comparative Review of Dopamine Receptor Agonists in Parkinsonʼs Disease
Uitti, R. J., & Ahlskog, J. E. (1996) · CNS Drugs · doi:10.2165/00023210-199605050-00006 · Cited by 88
Coldwell, M. C., Boyfield, I., Brown, T., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702673 · Cited by 77
??2-Adrenoceptor Antagonists: A New Approach to Parkinson??s Disease?
Brefel‐Courbon, C., Thalamas, C., Paul, H. P. S., Sénard, J., Montastruc, J., & Rascol, O. (1998) · CNS Drugs · doi:10.2165/00023210-199810030-00004 · Cited by 71
Demchyshyn, L. L., McConkey, F., & Niznik, H. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000157200 · Cited by 71
Dziewczapolski, G., Menalled, L., García, M. C., Mora, M. A., Gershanik, O. S., & Rubinstein, M. (1998) · Neuroreport · doi:10.1097/00001756-199801050-00001 · Cited by 66
Fariello, R. (1998) · Drugs · doi:10.2165/00003495-199855001-00002 · Cited by 63
Newman‐Tancredi, A., Audinot, V., Chaput, C., Verrièle, L., & Millan, M. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36804-1 · Cited by 55
Self-citationActivity and acceptability of piribedil in Parkinson's disease: a multicentre study
Rondot, P., & Ziegler, M. (1992) · Journal of Neurology · doi:10.1007/bf00819564 · Cited by 54
Karasinska, J. M., George, S. R., El-Ghundi, M., Fletcher, P. J., & O’Dowd, B. F. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00347-2 · Cited by 54
Gulwadi, A. G., Korpinen, C. D., Mailman, R. B., Nichols, D. E., Sit, S., & Taber, M. T. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38751-8 · Cited by 52
Millan, M. J., Brocco, M., Rivet, J., Audinot, V., Newman‐Tancredi, A., Maiofiss, L., Queriaux, S., Despaux, N., Péglion, J.-L., & Dekeyne, A. (2000) · PubMed · Cited by 49
Self-citationMillan, M. J., Cussac, D., Milligan, G., Carr, C., Audinot, V., Gobert, A., Lejeune, F., Rivet, J., Brocco, M., Duqueyroix, D., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29611-7 · Cited by 45
Self-citationKimura, K., Sela, S., Bouvier, C., Grandy, D. K., & Sidhu, A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052118.x · Cited by 44
Leysen, J. E., Gommeren, W., Mertens, J. J. R., Luyten, W. H. M. L., Pauwels, P. J., Ewert, M., & Seeburg, P. H. (1993) · Psychopharmacology · doi:10.1007/bf02246947 · Cited by 43
O’Donnell, J. M., Frith, S. A., & Wilkins, J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22769-0 · Cited by 36
Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies
Jackson, D., Mohell, N., Georgiev, J., Bengtsson, A., Larsson, L.-G., Magnusson, O., & Ross, S. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169328 · Cited by 35
Millan, M. J., Brocco, M., Rivet, J., Audinot, V., Newman‐Tancredi, A., Maiofiss, L., Queriaux, S., Despaux, N., Péglion, J.-L., & Dekeyne, A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35260-7 · Cited by 34
Self-citationNewman‐Tancredi, A., Cussac, D., Audinot, V., & Millan, M. J. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005374 · Cited by 27
Self-citationDopaminergic modulation of hippocampal noradrenaline release
Jackisch, R., Moll, S., Feuerstein, T. J., & Hertting, G. (1985) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499902 · Cited by 26
Niittykoski, M., Ruotsalainen, S., Haapalinna, A., Larson, J., & Sirviö, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00447-3 · Cited by 21
Markham, A., & Benfield, P. (1997) · CNS Drugs · doi:10.2165/00023210-199707040-00005 · Cited by 19
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Self-citationGonzález-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation
Schade, R., Andersohn, F., Suissa, S., Haverkamp, W., & Garbe, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062222 · Cited by 718
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Self-citation
Metadata
- Authors
- Millan, M. J., Maiofiss, L., Cussac, D., Audinot, V., Boutin, J.-A., & Newman-Tancredi, A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 303
- Issue
- 2
- Pages
- 791-804
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2168954492
- Cited by
- 484
- References
- 51
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.